Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.

Clinical trial NCT00050076 · COMPLETED

Trial details

NCT number: NCT00050076
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Congestive Heart Failure

Start date: 2002-08-01
Primary completion: 2003-08-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.